• Trelagliptin Succinate: Applied Protocols for Diabetes and O

  2026-05-20

  Trelagliptin succinate redefines experimental flexibility in diabetes and osteoarthritis research, backed by robust pathway modulation and high solubility. Discover advanced protocol guidance, troubleshooting solutions, and unique workflow enhancements that set this DPP-4 inhibitor apart for translational studies.

• Levofloxacin: Synthetic Fluoroquinolone Antibiotic in Advanc

  2026-05-20

  Levofloxacin empowers precision research in bacterial DNA replication inhibition, osteoblast growth modulation, and chondrocyte metabolism studies. This guide offers actionable workflows, troubleshooting tips, and novel insights from resistance genetics, positioning APExBIO’s Levofloxacin as a versatile tool for high-impact experimental designs.

• Cefodizime: Third-Generation Cephalosporin in AMR Research

  2026-05-19

  Cefodizime stands out as a third-generation cephalosporin antibiotic for modeling antimicrobial resistance and studying bacterial cell wall inhibition. Its stability against β-lactamases and immunomodulatory effects empower advanced microbiology workflows, especially in the context of multidrug-resistant E. coli from environmental sources.

• WM-8014: A Precision KAT6A Inhibitor for Epigenetic Research

  2026-05-19

  WM-8014 delivers highly selective, reversible inhibition of KAT6A and KAT6B, enabling precise oncogene-induced senescence induction without general cytotoxicity. This guide translates cutting-edge evidence into actionable workflows and troubleshooting strategies for advanced cancer biology and epigenetic research.

• Sodium dicloxacillin monohydrate: Analytical Precision and A

  2026-05-18

  Discover how sodium dicloxacillin monohydrate empowers Gram-positive bacterial infection research through robust analytical methodologies and advanced protocol optimization. This article uniquely bridges spectrophotometric insights with practical assay design, setting it apart from previous reviews.

• P2RX1 Drives Mitochondrial Apoptosis in Ph+ ALL via Ca2+/CaM

  2026-05-18

  Li et al. (2025) elucidate the role of P2RX1 in promoting mitochondrial apoptosis through a calcium/CaMKII-mediated suppression of PI3K/Akt signaling in Philadelphia chromosome-positive acute lymphoblastic leukemia. This mechanistic insight identifies P2RX1 as a potential therapeutic target for overcoming drug resistance and improving treatment outcomes in Ph+ ALL.

• Tariquidar (XR9576): Enhancing Drug Resistance Research Work

  2026-05-17

  Tariquidar (XR9576) redefines drug resistance research by enabling precise, selective inhibition of P-glycoprotein—even in complex, high-viscosity tumor microenvironments. Unlock robust protocols, advanced use-cases, and expert troubleshooting with this gold-standard ABC transporter inhibitor from APExBIO.

• Hepatic Interactions of PEGylated Iron Oxide Nanoparticles D

  2026-05-16

  This study systematically investigates how iron oxide nanoparticle size and PEGylation affect their hepatic cellular uptake and biodistribution in vivo. The findings challenge established assumptions about Kupffer cell dominance in nanoparticle clearance and provide guidance for optimizing nanoparticle design to reduce liver accumulation and enhance clinical translation.

• Cinoxacin in Urinary Tract Infection Research: Mechanism and

  2026-05-15

  This article examines the mechanistic, pharmacokinetic, and antimicrobial properties of Cinoxacin, a quinolone antibiotic, as detailed in the reference study. It highlights Cinoxacin’s rapid urinary concentration, activity against Gram-negative bacteria, and clinical implications for urinary tract infection research, while also discussing study limitations and best practices for laboratory use.

• Exercise-Induced Muscle EVs Enhance Microglial Amyloid Clear

  2026-05-15

  This study uncovers how exercise-driven secretion of skeletal muscle-derived extracellular vesicles (SKM-EVs) enhances microglial clearance of amyloid-beta plaques in Alzheimer's disease (AD) mouse models. The research identifies miR-378a-3p as a critical vesicular cargo mediating this effect, providing mechanistic insight into muscle-to-brain communication and supporting new therapeutic strategies for AD.

• Lipid Composition Tunes mRNA Lipoplex Efficacy in Systemic D

  2026-05-14

  This study systematically investigates how varying cationic and neutral lipid components in liposomal mRNA carriers influences systemic delivery, protein expression, and antibody induction in mice. The findings offer clear design principles for optimizing mRNA lipoplex formulations for immunization and gene expression, with implications for both vaccine and reporter assay development.

• Arginine Methylation and SMN Drive FUS Phase Separation in N

  2026-05-14

  Wang and Li (2024) reveal that asymmetric dimethylation of FUS enables multivalent interactions with SMN, facilitating phase separation crucial for neuronal granule formation. Their findings clarify how perturbations in arginine methylation or SMN function can disrupt mRNA transport and neuronal activity, offering new mechanistic insight into neurodegenerative disease processes.

• RESTRICT-seq Reveals KAT6A as Key Epigenetic Dependency in S

  2026-05-13

  The reference study introduces RESTRICT-seq, a time-gated CRISPR screening approach, to uncover previously unrecognized epigenetic vulnerabilities underlying squamous cell carcinoma (SCC) resistance. Notably, KAT6A emerged as a critical determinant of oncogene-induced senescence, highlighting new avenues for selective histone acetyltransferase inhibitor research.

• Diuron (3-(3,4-dichlorophenyl)-1,1-dimethylurea) in Toxicolo

  2026-05-13

  Diuron, a potent photosynthesis inhibitor, is not only essential for plant biology research but also provides a unique model for dissecting nephrotoxic mechanisms in environmental toxicology. This article translates cutting-edge findings into actionable workflows, highlights best practices for experimental use, and offers troubleshooting tips to maximize data quality with APExBIO’s high-purity Diuron.

• Gamithromycin (BA1074): Mechanism, Evidence, and Protocol In

  2026-05-12

  Gamithromycin (ML-1709460) is a 15-membered semi-synthetic macrolide antibiotic with potent activity against major veterinary respiratory pathogens. Evidence-backed PK/PD benchmarks support its dosing in bovine respiratory disease and Glässer’s disease treatment. This article details mechanism, validated exposure-response data, and workflow parameters for research and translational applications.

392 records 7/27 page Previous Next First page 上5页 678910 下5页 Last page